SCHEMBL19082321

SCHEMBL19082321

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5sc6c(ccc7c6sc6ccc8ccccc8c67)c5c4)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.35
CYP1B1 Q16678 2/20 0.35
ALOX5 P09917 1/20 0.34
LIMK1 P53667 1/20 0.33
NQO2 P16083 2/20 0.33
NQO1 P15559 1/20 0.33
F9 P00740 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
SOS1 Q07889 1/20 0.32
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
CYP1A2 P05177 3/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 2/20 0.30
MAPT P10636 1/20 0.30
FYN P06241 1/20 0.30
MAPK3 P27361 1/20 0.30
AHR P35869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082181 0.95 CYP1A1 (0.35) CYP1A1CYP1B1ALOX5LIMK1NQO2
SCHEMBL19082319 0.93 CYP1A1 (0.40) CYP1A1CYP1B1ALOX5LIMK1NQO2
SCHEMBL19082316 0.93 CYP1A1 (0.35) CYP1A1CYP1B1ALOX5LIMK1NQO2
SCHEMBL19082356 0.92 ALOX5 (0.40) CYP1A1CYP1B1ALOX5NQO2NQO1
SCHEMBL17932038 0.91 CYP1A1 (0.43) CYP1A1CYP1B1ALOX5LIMK1F9
SCHEMBL17932047 0.90 NQO2 (0.35) CYP1A1CYP1B1LIMK1NQO2NQO1
SCHEMBL19082213 0.90 LIMK1 (0.40) CYP1A1CYP1B1LIMK1NQO2NQO1
SCHEMBL19082147 0.90 CYP1A1 (0.38) CYP1A1CYP1B1ALOX5LIMK1NQO2
SCHEMBL19080304 0.89 CYP1A1 (0.41) CYP1A1CYP1B1NQO2NQO1F9
SCHEMBL19082176 0.88 CYP1A1 (0.34) CYP1A1CYP1B1ALOX5LIMK1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.